SARS-CoV-2

Based on the provided articles, SARS-CoV-2 is not an organization, but rather the name of the virus that causes COVID-19. The articles highlight two distinct but related issues. First, one article discusses the evolving treatment landscape for Long Covid in Germany, where statutory health insurance funds will soon cover certain prescription medications for Long Covid patients, improving access to treatment. This is newsworthy because previously, patients often had to pay for these medications themselves. Second, another article features an interview with Richard Hatchett, the CEO of CEPI, who warns that the world is not better prepared for a pandemic than it was before COVID-19; in fact, the risk is higher. This is relevant because it underscores the ongoing need for global pandemic preparedness efforts and highlights potential vulnerabilities in current systems. Both articles emphasize the continuing impact of the SARS-CoV-2 pandemic and the need for ongoing attention to both its long-term health consequences and the broader threat of future pandemics.